Member Info for jimbogains

It’s not in her hands. The deal will (or won’t) be done whenever it is. Bigger point is whether BOD should retain their positions when it next comes up for a vote.

If no cash coming in by AGM then the BOD really will need to go.

Fair enough porky, although I struggle to see what EUDA gets out of this if TRx aren’t bringing investment cash to the table. My positive mental attitude is still winning through anyway

Whilst I'm at risk of being the odd man out (and potentially completely wrong in terms of conclusion here), it's worth noting that there has still been no update from EUDA to the NYSE, which surely has to be a good sign. As with the UK stock market, there's a requirement for any material news to be provided to the US market ASAP where it could have a material impact on price. No news is... annoying but potentially good. If we get a positive announcement from EUDA, I can imagine us shooting up to 20p+ per share very rapidly (whether sustainable or not).

Valipharma is wholly owned by Valirx.

Inevitably, Valirx paid costs on behalf of Valipharma which it wasn't reimbursed for, and this created an intercompany receivable. As Valirx has both the payable (indirectly) and receivable (directly), it cancels out, i.e. it's irrelevant to the company's financial position.

It’s interesting that there have been no updates from EUDA despite exclusivity having passed, but no news implies that negotiations are ongoing.

That said, I’m struggling with timeline now. I had assumed that this was in essence a reverse takeover – i.e. the TheoremRx shareholders would in effect be issued EUDA shares in return for their shares in TheoremRx, and the TheoremRx shareholders would control EUDA after the transaction.

However, if correct, I think (!) from looking at the literature that this would need shareholder approval and that would require notice of at least 30 days under the NYSE listing rules.

So…

Afraid to say it, but given the lack of notice to date, my reading is that this is going to drag well into January before the deal completes and any money flows.

That said, clearly positive news from EUDA would be good for Val’s share price in the meantime. Hopefully it will give some indication of how much TRx is valued at too, so we can get a feel for what it’s got (in terms of cash, pipeline, etc).

Delays are frustrating, yes. But Suzy’s moving the company forward and her salary is hardly astronomical. If Suzy pulls off a deal and gets the share price significantly up, it will all have been worth it for all of us investors. Not long til news, positive or negative

Given US markets shut today and half day tomorrow, I assume that means no news expected this week

1pm tomorrow, I’m at least 20% sure we will have some great news. Whoooooooooop

I’m shooting for deal signed over the weekend, news released at 1pm UK time (8am EST) on Merger Monday

The parties will have an awful lot to get done to get this across the line… due diligence, structuring, SPA and commercial agreements… 30 days was always going to be tough. They may not even sign within the exclusivity period if there are still items to nail down. Importantly, we have had no indication that this isn’t going ahead. Be chill people, news will come!

If i've understood EUDA's problem correctly, its issue is that its share price and market cap are (or were until very recently) too low, so that it risked being automatically delisted. The proposed transaction is likely to be a reverse takeover, whereby the shareholders of TRx are issued with shares in EUDA in return for their shares in TRx.

This would only sort out the share price/MCap issue for EUDA if TRx is bringing tangible value to the table - obviously, given that new shares will need to be issued to TRx, which would otherwise dilute the share price. That value can only be in the form of ££££ cash.

So, I think it's pretty clear that TRx either has cash, or has committed funds.

It's not unreasonable to assume that the TRx funders will only permit the various payments TRx is on the hook for (including in relation to Val) to be made when they know they have a way of extracting their cash. Which would clearly be through them getting shares in a listed business.

Simples.

Fair enough. In any event, we are aligned in being super keen for positive news on EUDA. Really do hope we receive an update soon, I was surprised there wasn’t an announcement once the 30 days were up. I would imagine they have to issue something tomorrow.

Noted, but the reason for the share price doubling in recent weeks is only 201. Nothing else has changed.

All assets are priced in based on the market’s expectation of whether/when they go ahead or not. Cash is king. We need this deal.

To be fair, Porky is right. If there’s no sign of 201 completing or cash flowing soon, the share price will sink. However, we have many indications that it’s all lining up to proceed. I’m kinda hoping EUDA just buys Valirx for £500m or so and then I can move on with my life.

It will be interesting to see how TRx shareholders are compensated for selling their shares to EUDA - I assume all or substantially all in the form of EUDA shares. If so, what % of the company they get will be interesting, given that indicates what TRx is bringing to the table (ie cash, pipeline etc) compared to EUDA’s existing market cap.

Assuming the EUDA board recommends the merger, I’m guessing this needs to be put to a shareholder vote. Wonder how quickly they could turn this.

Is there any news at EUDA? 20% up but I assume speculative?

Out of interest, how easy would it be to short a small AIM company with limited daily trading volume? Presumably if easy enough then it's not cheap?

I must admit I really don't understand what Porky is trying to achieve here. However, the frequency of his posts is very similar to those when he was ramping a couple of years back. Give it a couple more years and i'm sure he'll be back on side.

30 day exclusivity agreement between EUDA and TRx comes to an end early next month. Should get some news then anyway, not long now! Appreciate there’s plenty of downside risk here, Porky… but fingers crossed you’re wrong. Squeaky bum time!

To be clear though - we are only expecting to get a couple of million, right? (Unless the deal changes and TRx wants to buy 201 or our other IP outright)

If TRx can’t fund that in the near future it will be very disappointing!